Identification of novel protein targets for modification by 15-deoxy-Delta12,14-prostaglandin J2 in mesangial cells reveals multiple interactions with the cytoskeleton.

The cyclopentenone prostaglandin 15-deoxy-Delta12,14-PGJ2 (15d-PGJ2) has been shown to display protective effects against renal injury or inflammation. In cultured mesangial cells (MC), 15d-PGJ2 inhibits the expression of proinflammatory genes and modulates cell proliferation. Therefore, cyclopentenone prostaglandins (cyPG) have been envisaged as a promise in the treatment of renal disease. The effects of 15d-PGJ2 may be dependent on or independent from its role as a peroxisome proliferator-activated receptor agonist. It was shown recently that an important determinant for the peroxisome proliferator-activated receptor-independent effects of 15d-PGJ2 is the capacity to modify proteins covalently and alter their function. However, a limited number of protein targets have been identified to date. Herein is shown that a biotinylated derivative of 15d-PGJ2 recapitulates the effects of 15d-PGJ2 on the stress response and inhibition of inducible nitric oxide synthase levels and forms stable adducts with proteins in intact MC. Biotinylated 15d-PGJ2 was then used to identify proteins that potentially are involved in cyPG biologic effects. Extracts from biotinylated 15d-PGJ2-treated MC were separated by two-dimensional electrophoresis, and the spots of interest were analyzed by mass spectrometry. Identified targets include proteins that are regulated by oxidative stress, such as heat-shock protein 90 and nucleoside diphosphate kinase, as well as proteins that are involved in cytoskeletal organization, such as actin, tubulin, vimentin, and tropomyosin. Biotinylated 15d-PGJ2 binding to several targets was confirmed by avidin pull-down. Consistent with these findings, 15d-PGJ2 induced early reorganization of vimentin and tubulin in MC. The cyclopentenone moiety and the presence of cysteine were important for vimentin rearrangement. These studies may contribute to the understanding of the mechanism of action and therapeutic potential of cyPG.

[1]  F. Cañada,et al.  Molecular Basis for the Direct Inhibition of AP-1 DNA Binding by 15-Deoxy-Δ12,14-prostaglandin J2* , 2003, Journal of Biological Chemistry.

[2]  C. Glass,et al.  15-deoxy-delta 12,14-prostaglandin J2 inhibits multiple steps in the NF-kappa B signaling pathway. , 2000, Proceedings of the National Academy of Sciences of the United States of America.

[3]  P. Maffia,et al.  Anti-Inflammatory Activity of 15-Deoxy-Δ12,14-PGJ2 and 2-Cyclopenten-1-one: Role of the Heat Shock Response , 2003 .

[4]  J. Morrow,et al.  Formation of Reactive Cyclopentenone Compounds in Vivo as Products of the Isoprostane Pathway* , 1999, The Journal of Biological Chemistry.

[5]  P. Csermely,et al.  Reactive cysteines of the 90-kDa heat shock protein, Hsp90. , 2000, Archives of biochemistry and biophysics.

[6]  B. Chait,et al.  Modification of cysteine residues by alkylation. A tool in peptide mapping and protein identification. , 1998, Analytical chemistry.

[7]  M. O’connor,et al.  Peroxisome Proliferator Activator Receptor-γ Ligands, 15-Deoxy-Δ12,14-Prostaglandin J2 and Ciglitazone, Reduce Systemic Inflammation in Polymicrobial Sepsis by Modulation of Signal Transduction Pathways 1 , 2003, The Journal of Immunology.

[8]  K. Stamatakis,et al.  Protein Thiol Modification by 15-deoxy-Δ12,14-Prostaglandin J2 Addition in Mesangial Cells: Role in the Inhibition of Pro-inflammatory Genes , 2004, Molecular Pharmacology.

[9]  E. J. Song,et al.  Oxidative modification of nucleoside diphosphate kinase and its identification by matrix-assisted laser desorption/ionization time-of-flight mass spectrometry. , 2000, Biochemistry.

[10]  L. Marnett,et al.  Requirement of a reactive α,β-unsaturated carbonyl for inhibition of tumor growth and induction of differentiation by “A” series prostaglandins , 1985 .

[11]  J. Morrow,et al.  Cellular mechanisms of redox cell signalling: role of cysteine modification in controlling antioxidant defences in response to electrophilic lipid oxidation products. , 2004, The Biochemical journal.

[12]  R. Breyer,et al.  Expression and Molecular Pharmacology of the Mouse CRTH2 Receptor , 2003, Journal of Pharmacology and Experimental Therapeutics.

[13]  J Auwerx,et al.  The peroxisome proliferator activated receptors (PPARS) and their effects on lipid metabolism and adipocyte differentiation. , 1996, Biochimica et biophysica acta.

[14]  F. Cañada,et al.  15-Deoxy-Δ12,14-prostaglandin J2Inhibition of NF-κB-DNA Binding through Covalent Modification of the p50 Subunit* , 2001, The Journal of Biological Chemistry.

[15]  E. Pineda‐Molina,et al.  15-Deoxy-Delta 12,14-prostaglandin J2 inhibition of NF-kappaB-DNA binding through covalent modification of the p50 subunit. , 2001, The Journal of biological chemistry.

[16]  M. Ward,et al.  Reversible cysteine-targeted oxidation of proteins during renal oxidative stress. , 2003, Journal of the American Society of Nephrology : JASN.

[17]  G. Natoli,et al.  Anti-inflammatory cyclopentenone prostaglandins are direct inhibitors of IκB kinase , 2000, Nature.

[18]  K. Itoh,et al.  Transcription Factor Nrf2 Regulates Inflammation by Mediating the Effect of 15-Deoxy-Δ12,14-Prostaglandin J2 , 2004, Molecular and Cellular Biology.

[19]  B. Rovin,et al.  Stress protein activation by the cyclopentenone prostaglandin 15-deoxy-delta12,14-prostaglandin J2 in human mesangial cells. , 2004, Kidney international.

[20]  P. Ghezzi,et al.  Identification by redox proteomics of glutathionylated proteins in oxidatively stressed human T lymphocytes , 2002, Proceedings of the National Academy of Sciences of the United States of America.

[21]  P. Klatt,et al.  PPAR Agonists Amplify iNOS Expression While Inhibiting NF-κB: Implications for Mesangial Cell Activation by Cytokines , 2002 .

[22]  M. Ward,et al.  Detection, Quantitation, Purification, and Identification of Cardiac Proteins S-Thiolated during Ischemia and Reperfusion* , 2002, The Journal of Biological Chemistry.

[23]  W. Fischer,et al.  Protein Disulfide Bond Formation in the Cytoplasm during Oxidative Stress* , 2004, Journal of Biological Chemistry.

[24]  F. Della Ragione,et al.  Purification and characterization of 5'-deoxy-5'-methylthioadenosine phosphorylase from human placenta. , 1986, The Journal of biological chemistry.

[25]  D. Solit,et al.  Hsp90: the vulnerable chaperone. , 2004, Drug discovery today.

[26]  P. Diegelman,et al.  Methylthioadenosine Phosphorylase Regulates Ornithine Decarboxylase by Production of Downstream Metabolites* , 2003, Journal of Biological Chemistry.

[27]  D. Straus.  15-deoxy Δ^ -PGJ2 inhibits multiple steps in the NF-kappaB signaling pathway , 2000 .

[28]  M. Santoro,et al.  Heat shock factors and the control of the stress response. , 2000, Biochemical pharmacology.

[29]  P. Poyet,et al.  Microtubule disruption induced in vivo by alkylation of beta-tubulin by 1-aryl-3-(2-chloroethyl)ureas, a novel class of soft alkylating agents. , 2000, Cancer research.

[30]  H. Masutani,et al.  Thioredoxin as a Molecular Target of Cyclopentenone Prostaglandins* , 2003, Journal of Biological Chemistry.

[31]  M. Breyer,et al.  Peroxisome proliferator-activated receptors (PPARs): novel therapeutic targets in renal disease. , 2001, Kidney international.

[32]  Wei Sha,et al.  Structural Identification by Mass Spectrometry of Oxidized Phospholipids in Minimally Oxidized Low Density Lipoprotein That Induce Monocyte/Endothelial Interactions and Evidence for Their Presence in Vivo * , 1997, The Journal of Biological Chemistry.

[33]  P. Cassidy,et al.  Electrophilic Prostaglandins and Lipid Aldehydes Repress Redox-sensitive Transcription Factors p53 and Hypoxia-inducible Factor by Impairing the Selenoprotein Thioredoxin Reductase* , 2003, The Journal of Biological Chemistry.

[34]  K. Itoh,et al.  Transcription factor Nrf2 regulates inflammation by mediating the effect of 15-deoxy-Delta(12,14)-prostaglandin j(2). , 2004, Molecular and cellular biology.

[35]  B. Rovin,et al.  Cyclopentenone prostaglandins inhibit cytokine-induced nf-kappab activation and chemokine production by human mesangial cells. , 2001, Journal of the American Society of Nephrology : JASN.

[36]  J. Jaén,et al.  Selective, covalent modification of beta-tubulin residue Cys-239 by T138067, an antitumor agent with in vivo efficacy against multidrug-resistant tumors. , 1999, Proceedings of the National Academy of Sciences of the United States of America.

[37]  R. Goldman,et al.  Motile Properties of Vimentin Intermediate Filament Networks in Living Cells , 1998, The Journal of cell biology.

[38]  E. J. Song,et al.  Rac1 regulates heat shock responses by reorganization of vimentin filaments: Identification using MALDI-TOF MS , 2001, Cell Death and Differentiation.

[39]  S. Cuzzocrea,et al.  15d-prostaglandin J2 reduces multiple organ failure caused by wall-fragment of Gram-positive and Gram-negative bacteria. , 2004, European journal of pharmacology.

[40]  J. Vázquez,et al.  S-nitrosylation of Hsp90 promotes the inhibition of its ATPase and endothelial nitric oxide synthase regulatory activities. , 2005, Proceedings of the National Academy of Sciences of the United States of America.

[41]  S. Narumiya,et al.  Site and mechanism of growth inhibition by prostaglandins. III. Distribution and binding of prostaglandin A2 and delta 12-prostaglandin J2 in nuclei. , 1987, The Journal of pharmacology and experimental therapeutics.

[42]  N. Kamiya,et al.  α,β-Unsaturated Ketone Is a Core Moiety of Natural Ligands for Covalent Binding to Peroxisome Proliferator-activated Receptor γ* , 2005, Journal of Biological Chemistry.

[43]  K. Inoki,et al.  15-Deoxy-Δ12,14-prostaglandin J2 inhibits IL-1β–induced cyclooxygenase-2 expression in mesangial cells , 2002 .

[44]  M. Sheetz,et al.  Concomitant changes in mitochondria and intermediate filaments during heat shock and recovery of chicken embryo fibroblasts , 1993, Journal of cellular biochemistry.

[45]  A. Doseff,et al.  15-Deoxy-Delta12,14-prostaglandin J2 regulates mesangial cell proliferation and death. , 2002, Kidney international.

[46]  F. Cañada,et al.  The cyclopentenone 15-deoxy-Δ12,14-prostaglandin J2 binds to and activates H-Ras , 2003, Proceedings of the National Academy of Sciences of the United States of America.

[47]  L. Landino,et al.  Modulation of the redox state of tubulin by the glutathione/glutaredoxin reductase system. , 2004, Biochemical and biophysical research communications.

[48]  N. Kamiya,et al.  Alpha,beta-unsaturated ketone is a core moiety of natural ligands for covalent binding to peroxisome proliferator-activated receptor gamma. , 2005, The Journal of biological chemistry.

[49]  Karim Benkirane,et al.  Vascular and Cardiac Effects in Hypertension , 2022 .

[50]  N. Patel,et al.  The cyclopentenone prostaglandin 15-deoxy-Delta(12,14)-prostaglandin J2 ameliorates ischemic acute renal failure. , 2004, Cardiovascular research.

[51]  M. Díaz-Guerra,et al.  Inhibition of IκB Kinase and IκB Phosphorylation by 15-Deoxy-Δ12,14-Prostaglandin J2 in Activated Murine Macrophages , 2000, Molecular and Cellular Biology.